Zeigler-Johnson CM - Search Results

1

Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR. Zeigler-Johnson CM, et al. Can J Urol. 2008 Feb;15(1):3872-82. Can J Urol. 2008. PMID: 18304397 Free PMC article. Review.

2

Association of HPC2/ELAC2 genotypes and prostate cancer.

Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB. Rebbeck TR, et al. Am J Hum Genet. 2000 Oct;67(4):1014-9. doi: 10.1086/303096. Epub 2000 Sep 12. Am J Hum Genet. 2000. PMID: 10986046 Free PMC article.

3

Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.

Zeigler-Johnson CM, Walker AH, Mancke B, Spangler E, Jalloh M, McBride S, Deitz A, Malkowicz SB, Ofori-Adjei D, Gueye SM, Rebbeck TR. Zeigler-Johnson CM, et al. Hum Hered. 2002;54(1):13-21. doi: 10.1159/000066695. Hum Hered. 2002. PMID: 12446983

4

CYP3A4: a potential prostate cancer risk factor for high-risk groups.

Zeigler-Johnson C. Zeigler-Johnson C. Clin J Oncol Nurs. 2001 Jul-Aug;5(4):153-4. Clin J Oncol Nurs. 2001. PMID: 12690615

5

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men.

Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR. Gueye SM, et al. Urology. 2003 May;61(5):987-92. doi: 10.1016/s0090-4295(02)02588-8. Urology. 2003. PMID: 12736021

6

Population differences in the frequency of the agouti signaling protein g.8818a>G polymorphism.

Zeigler-Johnson C, Panossian S, Gueye SM, Jalloh M, Ofori-Adjei D, Kanetsky PA. Zeigler-Johnson C, et al. Pigment Cell Res. 2004 Apr;17(2):185-7. doi: 10.1111/j.1600-0749.2004.00134.x. Pigment Cell Res. 2004. PMID: 15016309

7

Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors.

Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR. Spangler E, et al. Int J Cancer. 2005 Jan 20;113(3):471-4. doi: 10.1002/ijc.20578. Int J Cancer. 2005. PMID: 15455347 Free article.

8

CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.

Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. Zeigler-Johnson C, et al. Cancer Res. 2004 Nov 15;64(22):8461-7. doi: 10.1158/0008-5472.CAN-04-1651. Cancer Res. 2004. PMID: 15548719

9

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR. Rennert H, et al. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57. doi: 10.1158/1055-9965.EPI-04-0637. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824169

10

Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men.

Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Spangler E, et al. J Urol. 2007 Nov;178(5):1939-44; discussion 1945. doi: 10.1016/j.juro.2007.07.021. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page